Redo coronary artery bypass graft. Risk and results

The results of CABG surgery show its high clinical efficacy, but the number of patients with return of the angina clinic has been increasing since time. Currently, despite the development of pharmacology and endovascular technology, redoGABG remains one of the methods of treatment of recurrent angina in patients who underwent myocardial revascularization. Of course, there are a number of patients who can be effectively treated only by repeated myocardial revascularization. The availability of cardiosurgical assistance to the population, the large volume of CABG operations performed in clinics, contributes to the accumulation of surgical experience. However, the number of reCABG procedures in our country is still measured in tens. This is due to the initially heavier patients, the lack of experience in such operations, a priori higher surgical risk and unsatisfactory mortality rates. The results of aortocoronary bypass surgery show its high kinetic efficacy, however, since time of the category of patients with the return of the clinic for angina pectoris increases. The choice of surgical tactics, reducing the risks of re-operation and improving the results are still relevant.